- Home
- UUU vs APVO Comparison
UUU vs APVO Comparison
Compare UUU & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- APVO
- Stock Information
- Founded
- UUU 1969
- APVO 2016
- Country
- UUU United States
- APVO United States
- Employees
- UUU N/A
- APVO N/A
- Industry
- UUU Electronic Components
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- UUU Technology
- APVO Health Care
- Exchange
- UUU Nasdaq
- APVO Nasdaq
- Market Cap
- UUU 5.0M
- APVO 4.1M
- IPO Year
- UUU N/A
- APVO N/A
- Fundamental
- Price
- UUU $3.29
- APVO $3.03
- Analyst Decision
- UUU
- APVO Strong Buy
- Analyst Count
- UUU 0
- APVO 1
- Target Price
- UUU N/A
- APVO $5,920.00
- AVG Volume (30 Days)
- UUU 29.8K
- APVO 474.6K
- Earning Date
- UUU 08-18-2025
- APVO 08-07-2025
- Dividend Yield
- UUU N/A
- APVO N/A
- EPS Growth
- UUU N/A
- APVO N/A
- EPS
- UUU N/A
- APVO N/A
- Revenue
- UUU $22,168,402.00
- APVO N/A
- Revenue This Year
- UUU N/A
- APVO N/A
- Revenue Next Year
- UUU N/A
- APVO N/A
- P/E Ratio
- UUU N/A
- APVO N/A
- Revenue Growth
- UUU 5.57
- APVO N/A
- 52 Week Low
- UUU $1.11
- APVO $2.81
- 52 Week High
- UUU $3.99
- APVO $405.52
- Technical
- Relative Strength Index (RSI)
- UUU 60.28
- APVO 36.57
- Support Level
- UUU $3.08
- APVO $2.86
- Resistance Level
- UUU $3.60
- APVO $3.05
- Average True Range (ATR)
- UUU 0.27
- APVO 0.16
- MACD
- UUU -0.02
- APVO 0.21
- Stochastic Oscillator
- UUU 52.70
- APVO 50.00
About UUU Universal Security Instruments Inc.
Universal Security Instruments Inc is a U.S based manufacturer and distributor of safety and security devices in the Peoples Republic of China . The company markets a line of residential smoke and carbon monoxide alarms under the trade names UNIVERSAL and USI Electric. It also markets products to the electrical distribution trade such as electrical and lighting distributors as well as manufactured housing companies. Its product portfolio consists of smoke and fire alarms, carbon monoxide alarms, multi-gas alarms, universal smoke sensing technology, and plug-in alarms.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.